<DOC>
	<DOCNO>NCT01450241</DOCNO>
	<brief_summary>The purpose study determine whether short-course antibiotic therapy safe effective treatment cancer patient febrile neutropenia .</brief_summary>
	<brief_title>Short-term Antibiotic Treatment Unexplained Fever Solid Cancer Patients With Febrile Neutropenia</brief_title>
	<detailed_description>Febrile neutropenia remain major cause morbidity solid cancer patient . There unresolved question regard appropriate duration antibiotic treatment patient febrile neutropenia unknown origin . Current guideline recommend least seven day antibiotic treatment . Several study demonstrate safety early antibiotic discontinuation patient febrile neutropenia . We plan open label randomize control trial compare early antibiotic discontinuation accept prolonged antibiotic treatment protocol</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Adults &gt; 18 year provide sign informed consent Patients solid tumor , lymphoma , multiple myeloma chronic lymphocytic leukemia , regardless disease status previous chemotherapy Documented febrile neutropenia No clinically microbiologically document infection 72 hour Previous enrollment study Concurrent participation another interventional trial Severe sepsis septic shock Acute leukemia , autologous allogeneic hematopoietic stemcell transplantation Diarrhea suspect treat physician Irinotecan induce Any antibiotic treatment &gt; 48h last week enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Febrile neutropenia</keyword>
	<keyword>Unexplained fever</keyword>
	<keyword>Duration</keyword>
	<keyword>Short-term antibiotic treatment</keyword>
</DOC>